SVF Vaccines News and Activities

SVF Vaccines is owned by KDventures.

KDventures is a company listed under the stock ticker KDEV (SE).

They are in:

• Holding33%
• Medical Equipment33%
• Other33%

Acquisition, funding and merger involving KDventures.

• Karolinska Development will change its company name to KDventures on Feb 10, 2026. (posted on February 10 2026).
• KDventures has filed its IPO. Its stock ticker will be KDV. (posted on January 29 2026).

View the org chart displaying its 7 main executives

Most searched biographies at SVF Vaccines

• Raheleh Nassaji, Chief Executive Officer
• Jens Bäck, Founder and Board Member
• Richard Bethell, Board Member

Popular executive movements at SVF Vaccines

• Raheleh Nassaji has joined the company as Chief Executive Officer  (posted on February 11 2026).

Create your alert
to follow the executive moves at SVF Vaccines.

KDventures has 3,499 competitors including UnitedHealth Group (United States (USA)), Kaiser Permanente (United States (USA)) and HCA (United States (USA)).

Popular M&A news in Healthcare

• Adaptive Innovations has just announced a $50 Million fundraising (posted on June 4 2026).
• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
• Freeman Health System has acquired Northwest Health (posted on June 2 2026).

Popular contacts in Healthcare

• Ari Bousbib - Chairman and Chief Executive Officer at IQVIA
• Gregory Adams - Chief Executive Officer and Chairman of the Board at Kaiser Permanente
• Pablo Legorreta - Chairman of the Board, Founder and Chief Executive Officer at Royalty Pharma

Learn more about the Healthcare industry

Press releases by SVF Vaccines

• News | Svenska vaccinfabriken

Social media about SVF Vaccines

• SVF Vaccines on Wikipedia, Google News & Yahoo Finance
• SVF Vaccines on LinkedIn, X (Twitter) & YouTube